A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
about
Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder.Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial.Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications.Microglia and CNS Interleukin-1: Beyond Immunological Concepts.
P2860
A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A pilot, open-label, 8-week st ...... nt of bipolar I/II depression.
@en
A pilot, open-label, 8-week st ...... nt of bipolar I/II depression.
@nl
type
label
A pilot, open-label, 8-week st ...... nt of bipolar I/II depression.
@en
A pilot, open-label, 8-week st ...... nt of bipolar I/II depression.
@nl
prefLabel
A pilot, open-label, 8-week st ...... nt of bipolar I/II depression.
@en
A pilot, open-label, 8-week st ...... nt of bipolar I/II depression.
@nl
P2093
P2860
P50
P356
P1433
P1476
A pilot, open-label, 8-week st ...... ent of bipolar I/II depression
@en
P2093
Elisa Brietzke
Hanna O Woldeyohannes
Madeline Li
Mohammad Alsuwaidan
Rodrigo B Mansur
Valerie H Taylor
P2860
P304
P356
10.1111/BDI.12496
P577
2017-05-01T00:00:00Z